Rankings
▼
Calendar
ACAD Q3 2016 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
ACAD
ACADIA Pharmaceuticals Inc.
$4B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
$4M
74.9% margin
Operating Income
-$72M
-1374.3% margin
Net Income
-$72M
-1359.4% margin
EPS (Diluted)
$-0.61
QoQ Revenue Growth
+5330.9%
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$50M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$617M
Total Liabilities
$39M
Stockholders' Equity
$578M
Cash & Equivalents
$154M
← FY 2016
All Quarters
Q4 2016 →
